Clinical Trial Update: Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial investigates transplanting autologous adipose-derived stem cells as a treatment for acute spinal cord injury, spanning Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Autologous adipose-derived stem cells (adipose-derived stem cells)

Snippet

Sponsor: Tri Phuoc Biotechnology., JSC | Conditions: Acute Spinal Cord Injury | Phase 1, Phase 2 | Status: UNKNOWN